Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Central venous catheter (CVC) are intravascular devices used in clinical practice, namely to administer fluid therapy, parenteral nutrition, drugs, blood products, hemodynamic monitoring, also being a gateway to the collection of blood samples or laboratory monitoring.
The fully implanted central venous catheter (CVCTI) is a type of central venous access surgically placed, which is characterized by containing a subcutaneous reservoir that is accessed by puncturing the camera with a blunt needle, widely used in cancer patients. The fully implanted central venous catheter is recommended when there is a need for intermittent vascular access and of long duration.
The maintenance of the CVCTI, as it's the necessity, frequency, and method is subject of some controversy, with discrepancies between the various cancer centers and guidance documents, once they occur several different intervals and maintenance methods.
The objective of this study is to assess the necessity of frequent maintenance of fully implanted central venous catheter, still assuring its viability and holding the same or lower number incidence of complications.
Participants in this study are cancer patients with a CVC fully implanted for chemotherapy, in follow-up phase. Participants will be randomized in one of two arms: Maintenance with saline solution and no maintenance.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Arm 1 | Other | Saline solution maintenance of the Central venous catheter (CVC) |
|
| Arm 2 | Experimental | No maintenance of the Central venous catheter (CVC) |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Saline solution maintenance of the CVC | Procedure | Saline solution maintenance of the Central venous catheter (CVC) - Celsite IMPLANTOFIX from B|Braun, according to local standard procedures. |
| Measure | Description | Time Frame |
|---|---|---|
| Number of Adverse Events | The occurrence of any adverse event related to the use of the CVCTI, thus allowing to assess the difference between the 2 groups with as much data as possible. | Time since screening until follow-up visit (on average 20 months) |
| Measure | Description | Time Frame |
|---|---|---|
| Occurence of AE related with infectious complications | The occurrence of adverse events related to infectious complications in the 2 groups. | Time since screening until follow-up visit (on average 20 months) |
| Occurence of AE related with thrombotic complications |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Rosana Magalhaes | Contact | +351 253 027 249 | cro@ccabraga.org |
| Name | Affiliation | Role |
|---|---|---|
| Ema Alves | Serviço de Hospital de Dia, Hospital de Braga, EPE | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Serviço de Hospital de Dia, Hospital de Braga | Recruiting | Braga | 4710-243 | Portugal |
Not provided
| ID | Term |
|---|---|
| D009369 | Neoplasms |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| No maintenance of the CVC | Procedure | No maintenance of the Central venous catheter (CVC) - Celsite IMPLANTOFIX from B|Braun. Just visual inspection to local site of CVC insertion. |
|
|
The occurrence of adverse events related to thrombotic complications of both CVCTI and venous thrombosis in both groups. |
| Time since screening until follow-up visit (on average 20 months) |